Intermittent Hypoxia-initiated Plasticity in Humans
Phase 1/2
60
about 5 years
30–60
1 site in MI
What this study is about
This trial is testing a new treatment called Mild Intermittent Hypoxia (MIH) to see if it can help people with sleep apnea and related health problems. The goal is to determine if repeated exposure to mild intermittent hypoxia reduces heart and blood vessel dysfunction, tiredness/fatigue experienced while exercise performance, and improves upper airway stability and sleep quality.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Mild Intermittent Hypoxia
- 2.Sham MIH
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Change in Blood Pressure
Secondary: Change in Sympatho-Vagal Balance (Blood Pressure Variability), Change in Sympatho-Vagal Balance (Heart Rate Variability)